Integrated Healthcare Systems

Integrated Health Systems (IHS) is a biotechnology company focused on the clinical implementation of advanced gene therapies and regenerative medicine to combat aging and age-related chronic diseases. Founded by Elizabeth Parrish, the company operates a unique medical tourism model that facilitates patient access to experimental genetic interventions in international jurisdictions with favorable regulatory environments. IHS collaborates with research organizations, most notably BioViva, to translate longevity science into therapeutic protocols targeting conditions such as sarcopenia, cognitive decline, and metabolic dysfunction. Their portfolio includes therapies utilizing telomerase reverse transcriptase (TERT) and myostatin inhibitors delivered via viral vectors. The company provides a comprehensive service suite including personalized medicine, diagnostic testing, and long-term health monitoring for individuals seeking to extend their biological healthspan.